Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03184454 · ClinicalTrials.gov registry record · NA

Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder

A NA study of Obsessive - Compulsive Disorder, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
2
Enrollment target
2
Study locations

NCT03184454 is a NA study of Obsessive - Compulsive Disorder that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 2 participants, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03184454, a NA study of Obsessive - Compulsive Disorder, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
2 participants
Enrollment target
2
Study locations

Study Summary

This study involves the use of the Medtronic PC+S deep brain stimulation for the treatment of intractable OCD.

Interventions

  • DEVICE Medtronic Percept Deep Brain Stimulation

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Charlestown

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2019-03-01
Est. Completion 2026-10-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03184454

The ClinicalTrials.gov registry entry for NCT03184454 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Percept Deep Brain Stimulation is the first listed.

NCT03184454 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03184454 about?

NCT03184454 is a clinical study titled "Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder". This study involves the use of the Medtronic PC+S deep brain stimulation for the treatment of intractable OCD.

What is the current status of trial NCT03184454?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2019-03-01. Estimated completion is 2026-10-31.

What conditions does trial NCT03184454 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT03184454?

The interventions under investigation include: Medtronic Percept Deep Brain Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03184454?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03184454 being conducted?

This trial has 2 study locations across Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.